Ignite Creation Date:
2024-05-06 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252988
Status:
RECRUITING
Last Update Posted:
2023-12-15
First Post:
2022-02-02
Brief Title:
Three Antidiarrheal Strategies in HER2HR Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
Sponsor:
Spanish Breast Cancer Research Group
Organization:
Spanish Breast Cancer Research Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hormone Receptor Positive |
| Early-stage Breast Cancer |
| HER2 Positive Breast Cancer |